Post hoc responder analysis of health-related quality of life (HRQL) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel in the phase III PROSELICA and FIRSTANA trials

Affiliation auteurs!!!! Error affiliation !!!!
TitrePost hoc responder analysis of health-related quality of life (HRQL) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel in the phase III PROSELICA and FIRSTANA trials
Type de publicationJournal Article
Year of Publication2018
AuteursA. Vuillemin T, Fizazi K., Sartor O., Oudard S., Bury D., Guillonneau S., Ozatilgan A., Eisenberger M., de Bono J.S
JournalANNALS OF ONCOLOGY
Volume29
Pagination281
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534